Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Blair Kaplan"'
Autor:
Kenneth B. Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C. Coates, Filip E. Van den Bosch, Blair Kaplan, Willem Koetse, Doug G. Ashley, Ralph Lippe, Ranjeeta Sinvhal, Kim A. Papp
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2523-2538 (2024)
Abstract Introduction Risankizumab has demonstrated a favourable safety profile in patients with psoriatic disease (moderate-to-severe psoriasis [PsO] and psoriatic arthritis [PsA]). We evaluated the long-term safety of risankizumab in psoriatic dise
Externí odkaz:
https://doaj.org/article/83030d6abf4e47649d18fb5fdcb77867
Autor:
Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Roberto Ranza, Blair Kaplan, Linyu Shi, Byron Padilla, Ahmed M. Soliman, Dennis McGonagle
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 6, Pp 1517-1530 (2024)
Abstract Introduction The presence (vs absence) of enthesitis/dactylitis is associated with greater psoriatic arthritis (PsA) activity and reduced health-related quality of life. Risankizumab, an interleukin 23 antagonist, demonstrated superior treat
Externí odkaz:
https://doaj.org/article/208376fab02442ef8617f079f73a4f2b
Autor:
Joseph F. Merola, April Armstrong, Saakshi Khattri, So Yeon Paek, Byron Padilla, Cuiyong Yue, Huzefa Photowala, Blair Kaplan, Lars Erik Kristensen
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractIn the KEEPsAKE 1 (NCT03675308) and KEEPsAKE 2 (NCT03671148) phase 3 trials, risankizumab demonstrated greater efficacy compared with placebo in patients with active psoriatic arthritis (PsA). This post hoc integrated analysis evaluated achie
Externí odkaz:
https://doaj.org/article/39e61f6277034f2f88e208b5a6fe086b
Autor:
Andrew Blauvelt, Barry Ladizinski, Vimal H. Prajapati, Vivian Laquer, Alison Fischer, Samantha Eisman, Xiaofei Hu, Tianshuang Wu, Brian M. Calimlim, Blair Kaplan, Yingyi Liu, Henrique D. Teixeira, John Liu, Kilian Eyerich
Publikováno v:
Journal of the American Academy of Dermatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::373eb04c91817af4fc48bd24a9992b95
https://doi.org/10.1016/j.jaad.2023.05.033
https://doi.org/10.1016/j.jaad.2023.05.033
Autor:
Gregory Blair Kaplan, Roger Wright
Publikováno v:
Hispanic Review. 62:109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0100bae9e48f66cf1cf282e58b73d331
https://doi.org/10.2307/474437
https://doi.org/10.2307/474437
Autor:
Marshall Tague, Sean Cosgriff, Kimmai Nguyen, Vida Almario Passero, D Patrick Boyle, Lindsay Kaster, Sherrie L. Aspinall, Jenna Shields, Alice C. Leone, Doug Smith, Lymaris Cruz-Diaz, Shane Fishco, Irvin Molina, Xinhua Zhao, Carmela Jean, John Szymanski, Kenneth J. Smith, Kan Lu, Rebeca Calderon-Vargas, Roslyn A. Stone, Tanja Lepir, Bernadette B. Heron, Blair Kaplan, Gurkamal Chatta, Jenna Carmichael, Chester B. Good, Renee Rogers, Allen Ha, Sean Keefe, Sherry Giberti, Jessica Motta, Francesca E. Cunningham, Megan Sartore, Ivy Tonnu-Mihara, Linda Clifford, Brian Glovack, Shawn Depcinski, Jolynn K. Sessions, Mark C. Geraci, Janelle Maland
Publikováno v:
BMC Cancer
Background Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb5abe5e17d8369b2fb1473495b5073